Ajanta Pharma Stock Forecast

Stock Price Forecast

According to 14 analysts polled by S&P Global, Ajanta Pharma stock has a consensus rating of "Strong Buy" and an average price target of ₹3,303. The average 1-year stock price forecast is 7.77% higher than the current stock price, while the lowest is ₹2,605 (-15.01%) and the highest is ₹3,829 (+24.92%).

Price Target: ₹3,303 (+7.77%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	₹2,605	₹3,303	₹3,363	₹3,829
Change	-15.01%	+7.77%	+9.70%	+24.92%

* Price targets were last updated on Feb 1, 2026.

Analyst Ratings

The average analyst rating for Ajanta Pharma stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Apr '26	May '26	Jun '26
Strong Buy	9	9	9	9	11	11
Buy	1	1	1	1	1	1
Hold	1	0	0	0	0	0
Sell	2	2	2	2	1	1
Strong Sell	0	0	0	0	0	0
Total	13	12	12	12	13	13

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Unknown Analyst ICICI Securities No rating	ICICI Securities	Buy Maintains ₹3,270	Buy	Maintains	₹3,270	+6.68%	Feb 1, 2026
Unknown Analyst Motilal Oswal No rating	Motilal Oswal	Buy Maintains ₹3,145	Buy	Maintains	₹3,145	+2.60%	Dec 29, 2025

Financial Forecast

Revenue This Year

62.67B

from 54.53B

14.93%

from 54.53B

Revenue Next Year

70.33B

from 62.67B

12.22%

from 62.67B

EPS This Year

98.31

from 84.51

16.33%

from 84.51

EPS Next Year

113.89

from 98.31

15.85%

from 98.31

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Mar 31, 2022	Mar 31, 2023	Mar 31, 2024	Mar 31, 2025	Mar 31, 2026	Mar 31, 2027
Revenue	33.41B	37.43B	42.09B	46.48B	54.53B	62.67B
Revenue Growth	15.62%	12.02%	12.45%	10.44%	17.31%	14.93%
Gross Profit	24.57B	26.32B	30.88B	35.05B	42.69B	48.61B
Gross Margin	73.54%	70.34%	73.36%	75.41%	78.29%	77.57%
Operating Income	8.08B	6.80B	10.46B	11.28B	13.25B	15.59B
Net Income	7.13B	5.88B	8.16B	9.20B	10.56B	12.26B
EPS	-	-	-	-	84.51	98.31
EPS Growth	-	-	-	-	14.93%	16.33%
Forward PE	19.55	20.52	31.03	31.53	29.29	31.18
Dividend / Share	6.33	7.00	36.00	28.00	28.00	39.89
Dividend Growth	-	10.53%	414.29%	-22.22%	-	42.46%
Free Cash Flow	1.89B	8.15B	1.16B	6.62B	8.68M	7.61B
No. Analysts	-	-	-	-	-	13

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.

Revenue Forecast

Revenue	2027	2028	2029
High	64.4B
Avg	62.7B
Low	60.1B

Revenue Growth

Revenue Growth	2027	2028	2029
High	18.1%
Avg	14.9%
Low	10.2%

EPS Forecast

EPS	2027	2028	2029
High	102.90
Avg	98.31
Low	93.73

EPS Growth

EPS Growth	2027	2028	2029
High	21.8%
Avg	16.3%
Low	10.9%